Cranial nerves and ganglia are altered after in vitro treatment of mouse embryos with valproic acid (VPA) and 4-en-VPA
- 1 May 1996
- journal article
- Published by Elsevier in Developmental Brain Research
- Vol. 93 (1-2) , 62-69
- https://doi.org/10.1016/0165-3806(96)00031-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- In vitro neuroteratogenicity of valproic acid and 4-en-VPANeurotoxicology and Teratology, 1995
- Rhombomères, code Hox, crête neurale et malformations de la facemédecine/sciences, 1994
- Development of cranial nerves in the chick embryo with special reference to the alterations of cardiac branches after ablation of the cardiac neural crestBrain Structure and Function, 1991
- Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: An interspecies comparisonTeratology, 1988
- Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley ratsFundamental and Applied Toxicology, 1988
- Verification of the fetal valproate syndrome phenotypeAmerican Journal of Medical Genetics, 1988
- Congenital Malformations Associated with Maternal Use of Valproic AcidCanadian Journal of Neurological Sciences, 1987
- Cephalic ectodermal placodes and neurogenesisTrends in Neurosciences, 1986
- Fetal valproate syndromeAmerican Journal of Medical Genetics, 1986
- The fetal valproate syndromeAmerican Journal of Medical Genetics, 1984